Navigation Links
Caris Diagnostics Announces Addition of Leading Dermatopathologist to Expand Subspecialty Expertise
Date:1/15/2008

IRVING, Texas, Jan. 15 /PRNewswire/ -- Caris Diagnostics, a leading provider of diagnostic services in anatomic pathology and molecular testing, today announced the hiring of another nationally renowned dermatopathologist for its Phoenix laboratory. Iftikhar "Ifty" Ahmed, M.D. has joined Caris Diagnostics to support the growing dermatopathology practice for the company.

"Dr. Ahmed has been a leader in the dermatopathology community for years, with his proven commitment to patient care, teaching, and research. We are pleased to add Dr. Ahmed to our growing team of high quality dermatopathologists at Caris Dx," commented Gail Marcus, President and Chief Executive Officer of Caris Diagnostics. "This outstanding addition reinforces our commitment to the highest level of subspecialty expertise as we expand the scope of our services to the healthcare community."

Dr. Ahmed joins Caris Diagnostics from the Mayo Clinic and Mayo Foundation in Rochester, MN, where he practiced for fourteen years. Most recently, he was Professor of Dermatology, Director of Dermatopathology, and Co-Director of the Dermatopathology Fellowship at the Mayo Clinic. Dr. Ahmed is board certified in Anatomic Pathology, Dermatology and Dermatopathology. He is on the editorial boards of American Journal of Dermatopathology, Dermatologic Surgery, Journal of American Academy of Dermatology, and he is Section Editor of International Journal of Dermatology. Dr. Ahmed holds the office of Vice President of the Federation for International Dermatologic Education, which provides travel and educational grants for continued education to developing countries. He has been an active lecturer at international and national meetings including the Annual Meetings of the American Society of Dermatopathology and the American Academy of Dermatology.

"The ability to attract someone of Dr. Ahmed's stature demonstrates that our goal of providing academic-caliber medicine in a commercial setting is recognized and appreciated among the medical community," concluded Richard H. Lash, M.D., Chief Medical Officer of Caris Diagnostics. "We have found that our dedication to providing the highest level of subspecialty diagnostics in a supportive environment that includes research and education is appealing to the finest pathologists in the country."

About Caris Diagnostics

Caris Diagnostics is a leading provider of the highest quality diagnostic services in anatomic pathology and molecular testing. Caris Diagnostics provides world-class surgical pathology services to physicians who treat patients in an ambulatory setting. The company provides academic-caliber medical consults through its industry-leading team of subspecialty fellowship and expert-trained pathologists in gastrointestinal and liver pathology and dermatopathology. Caris Diagnostics provides the highest levels of service to its customers and their patients through its state-of-the-art laboratories; proprietary, advanced clinical and technology solutions; and rigorous quality assurance programs. Through the cutting-edge testing facilities of Caris MPI, the company also offers advanced analysis of patient samples through prognostic testing services and genomic and proteomic profiling to help guide physicians in the treatment of cancer and other complex diseases. As well, Caris MPI offers a single-source solution for biospecimen procurement, storage, tracking, analysis and reporting for research institutes, pharmaceutical and diagnostic companies and medical centers. More than 1,500 physicians nationally use Caris Diagnostics. Formed in 1996, the company is headquartered in Irving, Texas and operates four laboratories: Irving, Texas; Phoenix, Arizona (2 sites); and Newton, Massachusetts. Additional information is available at http://www.carisdx.com.


'/>"/>
SOURCE Caris Diagnostics
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. FDA Approves SOMA(R) (carisoprodol) 250 mg
2. Dominion Diagnostics Supports Rhode Islands Toys for Tots Initiative at Its 2007 Holiday Celebration
3. Quest Diagnostics to Speak at the Merrill Lynch Health Services Investor Conference
4. Studies Investigate Diagnostic Performance and Reproducibility of Pathwork Diagnostics Tissue of Origin Test
5. DeviceSpace Career Fair Opens Doors for Hundreds of Medical Device and Diagnostics Career Candidates
6. QED International Associates Announces Changes to the HealthShares(TM) Composite, and the HealthShares(TM) Diagnostics Indexes
7. GSW Worldwide Named Agency of Record for BioBehavioral Diagnostics Companys MMAT/ADHD(TM) System
8. Quest Diagnostics Licenses Technology Underlying SensiTrop(TM) HIV Co-Receptor Tropism Test from Pathway Diagnostics
9. ICx Technologies and Siemens Medical Solutions Diagnostics Enter In Vitro Diagnostics Development and License Option Agreement
10. Quest Diagnostics Reports Third Quarter Results
11. Optherion Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostics Based on Chromosome 10 Genetic Variations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... The OSHA Training ... Institute Education Center headquartered in Northern California, has issued an important reminder to ... their worksites. Employers with workers exposed to high temperatures should establish a ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... "FCPX editors ... customizable inside of Final Cut Pro X," said Christina Austin - CEO of Pixel ... style. Final Cut Pro X users can now reveal the media of ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... health professionals, announced today its affiliation with Tennessee Counseling Association. This ... the network of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is underway. ... transport experience for the millions of people who require these medical transport services ... industry through the use of technology. Now, SmartEMS has put forth an industry-changing ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 26, 2016 One of Australia,s ... formation of a new biotechnology company, Noxopharm Limited [ABN 50 608 ... IPO and to list on the ASX. Noxopharm is ... to enter a Phase 1 clinical study later this year. ... one of the biggest problems facing cancer patients - the ability ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals plc ... period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, ... of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ... (Eastern Daylight Time). As previously announced on ... a definitive merger agreement under which Jazz Pharmaceuticals has ...
(Date:6/26/2016)... 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) ... measures required to build a strong and stable market ... listed on the OTC Markets-pink current trading platform. ... "We are seeing an anomaly in market trading activities ... by the Company, but shareholders and market players as ...
Breaking Medicine Technology: